Silver Sponsor

Pharm-Olam is helping biopharmaceutical companies create a healthier world as a global, midsized CRO that offers agile, innovative and customized clinical solutions in support of Phase I-IV clinical research, with a specialization in infectious disease and vaccines. Since 2010, Pharm-Olam has supported 50% of all the antibiotics approved by the FDA and has over 15 years supporting government funded research in emerging and re-emerging infectious disease and vaccines. As a global CRO, Pharm-Olam understands the unique challenges presented in these areas. We realize that clinical research is a journey and go the distance.